School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR.
Biopharm Drug Dispos. 2012 Dec;33(9):487-500. doi: 10.1002/bdd.1815. Epub 2012 Sep 25.
Baicalein (B), wogonin (W) and oroxylin A (OA) are major components in Radix Scutellariae with similar pharmacokinetic properties. Due to the co-presence of these three flavones in herbal formulations for Radix Scutellariae, they are likely consumed together. The aim of this study is to investigate whether the pharmacokinetics of individual flavones is influenced by each other and the underlying mechanism of the interaction. Various systems were utilized in the current study including a rat in vivo study, a Caco-2 cell monolayer model and a rat in situ single-pass intestinal perfusion as well as in vitro enzymatic kinetics studies. The B, W and OA given singly as well as in a mixture were administered and the corresponding pharmacokinetic parameters were calculated and compared. After co-administration of the three flavones to rats, OA absorption increased significantly in comparison with when OA was administered alone. Mechanistic studies on the Caco-2 cell monolayer and rat in situ single-pass intestinal perfusion models revealed that co-administration of B, W and OA could significantly enhance their absorption and decrease the extent of phase II metabolism. Further in vitro enzymatic study and a transport study in transfected MDCK cells revealed that metabolic competition rather than membrane transporters might contribute to the pharmacokinetic interactions. The co-presence of multiple active components would result in metabolic interactions, which may induce further changes in pharmacodynamics.
黄芩素(B)、汉黄芩素(W)和白杨素(OA)是黄芩中的主要成分,具有相似的药代动力学特性。由于这些三种黄酮类化合物存在于黄芩的草药配方中,因此它们可能会一起被摄入。本研究旨在探讨个体黄酮类化合物的药代动力学是否会受到彼此的影响以及相互作用的潜在机制。本研究采用了各种系统,包括大鼠体内研究、Caco-2 细胞单层模型和大鼠在体肠灌流以及体外酶动力学研究。单独给予 B、W 和 OA 以及混合物,并计算和比较相应的药代动力学参数。当将三种黄酮类化合物共同给予大鼠时,与单独给予 OA 相比,OA 的吸收明显增加。在 Caco-2 细胞单层和大鼠在体肠灌流模型中的机制研究表明,共同给予 B、W 和 OA 可显著增强它们的吸收并减少 II 期代谢的程度。进一步的体外酶学研究和转染 MDCK 细胞的转运研究表明,代谢竞争而不是膜转运体可能是药代动力学相互作用的原因。多种活性成分的共存会导致代谢相互作用,这可能会导致药效学进一步变化。